How our product contributed to a scientific study

Cancer research with Lullaby

  • Introduction of the user and study context
  • Lullaby in this Study 
  • Study results and the impact of our product

Introduction of the user and study context

Who are the users?

Our product was purchase by a renowned group of researchers in the field of biosciences. They have recently published an article titled "Phenotypic profiling of solute carriers characterizes serine transport in cancer." This article is a significant contribution to cancer research, and we are proud that our transfection reagent Lullaby, played a role in this achievement.

What was the users’ study about?

The study aimed to explore the role of solute carriers in serine transport in cancer. Serine is an amino acid that plays a crucial role in the growth and survival of cancer cells. Understanding how serine is transported in these cells could pave the way for new cancer therapies. 

Lullaby in this study

Introduction of our product 

Lullaby is a high-quality siRNA transfection reagent. It has been specifically developed for transfecting siRNA into a variety of cell lines. Small interfering RNA (siRNA) is a molecule that can inhibit the expression of specific genes. By using Lullaby to transfect siRNA, researchers can study the role of specific genes in cells.

How they used our product in their study

In their study, the group of researchers used Lullaby to transfect siRNA into cancer cells. This inhibited the expression of certain solute carriers, allowing them to study their role in serine transport. Thanks to the efficiency and reliability of Lullaby, the research group was able to obtain precise and reproducible results.

Study results and the impact of our product

Results obtained in the study

The study revealed that certain solute carriers play a key role in serine transport in cancer cells. This discovery could have significant implications for the development of new cancer therapies. For example, it might be possible to target these solute carriers to reduce the availability of serine for cancer cells, inhibiting their growth.

The impact of our product on the study and future work 

Our product, Lullaby, enabled efficient and reliable siRNA transfection, leading to precise and reproducible results.

We take pride in contributing to significant research and look forward to seeing how our product can foster future scientific discoveries. We are committed to consistently delivering high-quality products that meet the needs of our customers. We are confident that you will find our product useful and effective for your research endeavors. Feel free to contact us for more information. Thank you for choosing us as your research partner. We are eager to assist you and look forward to continuing our collaboration in the future.

Learn more about

Reference : Papalazarou, V., Newman, A.C., Huerta-Uribe, A. et al. Phenotypic profiling of solute carriers characterizes serine transport in cancer. Nat Metab 5, 2148–2168 (2023).